01—Abstract
Summary
Summary of the 10-K filed February 20, 2015. Cited figures are marked; the original filing is the authoritative source.
Cboe Global Markets, Inc. (CBOE) reported robust performance in its 2014 10-K filing, driven by strong trading volumes across its diverse product offerings, including index options, equity options, and ETP options.
The company experienced a significant increase in total contract volume, up 11.6%a year-over-year, largely fueled by growth in proprietary products like SPX and VIX options and futures. Transaction fees remained the primary revenue driver, accounting for over 70% of total operating revenues. Cboe continued to focus on its growth strategies, including international expansion, development of innovative proprietary products, and enhancement of its trading systems, positioning itself for continued success in the derivatives market.
The company's financial health appeared solid, with increasing operating revenues and a stable expense-to-revenue ratio. Cboe also actively returned capital to shareholders through dividends and share repurchases.
However, the company highlighted potential risks, including intense price competition in the multiply-listed options market and the critical dependence on exclusive licensing agreements for key index products, such as the S&P 500 Index. Regulatory compliance and system integrity were also noted as ongoing priorities, with significant investments made in technology and adherence to evolving regulatory frameworks.
02—Key points
Key Highlights
- Total operating revenues increased by 7.9% to $617.2 million in 2014.
- Total contract volume saw an 11.6% increase, reaching 1.325 billion contracts in 2014.
- Transaction fees, the largest revenue source, grew by 10.2% to $437.8 million.
- Proprietary products, particularly SPX and VIX options and futures, showed significant volume growth.
- Cboe maintained a strong market share, with 29.9% of total U.S. exchange-traded options contracts in 2014.
- The company actively returned capital to shareholders through dividends and a $400 million share repurchase program.
- Risks include intense price competition and reliance on exclusive licensing for key index products.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2014filed February 20, 2015Financial Statements
FY2014 against FY2013
| Line item | FY2014FY2013 | Change |
|---|---|---|
| Revenue | $617.23M$572.05M | +7.9% |
| Operating Expenses | $303.42M$286.24M | +6.0% |
| Operating Income | $313.80M$285.81M | +9.8% |
| Interest Expense | $0$0 | — |
| Net Income | $189.71M$176.00M | +7.8% |
| EPS (Basic) | $2.21$1.99 | +11.1% |
| EPS (Diluted) | $2.21$1.99 | +11.1% |
| Shares Outstanding (Basic) | 85.41M87.33M | −2.2% |
| Shares Outstanding (Diluted) | 85.41M87.33M | −2.2% |
05—Questions
Frequently Asked Questions
What were Cboe's primary sources of revenue in 2014?
Cboe's primary source of revenue in 2014 was transaction fees, which represented 70.9% of its total operating revenues. Other significant revenue streams included access fees, market data fees, regulatory fees, and exchange services and other fees.
How did Cboe's trading volume perform in 2014?
Cboe experienced a significant increase in trading volume in 2014, with total contract volume growing by 11.6% to 1.325 billion contracts. Average daily volume (ADV) also increased by 11.6% to 5.26 million contracts.
What are the main risks Cboe identified in its 2014 filing?
Cboe identified several key risks, including intense price competition in the multiply-listed options market, the potential loss of exclusive rights to list key index options (like the S&P 500), and the general risks associated with operating in a highly regulated industry. System failures and cybersecurity threats were also highlighted.
How is Cboe managing its proprietary products and exclusive licenses?
Cboe is focused on developing and promoting its proprietary products, such as VIX and SPX options and futures, which contribute significantly to its revenue. The company also emphasizes the importance of its exclusive licensing agreements for products like S&P 500 options and notes the risks associated with potential non-renewal or loss of these exclusive rights.
06—Continue